Fuad El-Hibri
2020
In 2020, Fuad El-Hibri earned a total compensation of $3.2M as Executive Chairman of the Board of Directors at Emergent BioSolutions, a 7% increase compared to previous year.
Compensation breakdown
| Option Awards | $815,051 |
|---|---|
| Salary | $1,192,202 |
| Stock Awards | $1,200,046 |
| Other | $6,185 |
| Total | $3,213,484 |
El-Hibri received $1.2M in stock awards, accounting for 37% of the total pay in 2020.
El-Hibri also received $815.1K in option awards, $1.2M in salary and $6.2K in other compensation.
Rankings
In 2020, Fuad El-Hibri's compensation ranked 3,623rd out of 13,090 executives tracked by ExecPay. In other words, El-Hibri earned more than 72.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,623 out of 13,090 | 72nd |
Division Manufacturing | 1,420 out of 5,621 | 75th |
Major group Chemicals And Allied Products | 534 out of 2,254 | 76th |
Industry group Drugs | 464 out of 1,954 | 76th |
Industry Pharmaceutical Preparations | 350 out of 1,459 | 76th |
Pay ratio
| Fuad El-Hibri's Pay | $3,213,484 |
|---|---|
| Median Employee's Pay | $128,545 |
| Pay Ratio | 25to 1 |
In 2020, the annual total compensation of Fuad El-Hibri was $3,213,484.
The annual total compensation of the median employee at Emergent BioSolutions was $128,545.
The ratio of Fuad El-Hibri's pay to the pay of median employee was therefore 25 to one.
Source: SEC filing on April 9, 2021.
El-Hibri's colleagues
We found four more compensation records of executives who worked with Fuad El-Hibri at Emergent BioSolutions in 2020.